Precision for Medicine

Precision for Medicine acquires Applied Immunology

Thursday, May 5, 2016

Precision for Medicine, part of the Precision Medicine Group, has acquired Applied Immunology, which focuses in the creation and delivery of custom cell-based and immunoassay solutions. Applied Immunology supports innovative and targeted therapeutics developers across all areas, ranging from immuno-oncology to rare diseases to biosimilars from research to post-approval. Applied Immunology’s client base includes some of the most pioneering new venture-backed startups, along with many major global pharmaceutical firms. 

[Read More]

Precision for Medicine acquires Precision Health Economics

Friday, April 17, 2015

Precision for Medicine, a Bethesda, Md.- based specialized services company supporting next-generation approaches to drug development and commercialization, has acquired Precision Health Economics (PHE), a health economics consultancy and analytics firm. PHE leverages the experience of policy analysts, economists, clinicians and academics to advance research on the most complex healthcare questions. Life sciences companies and policymakers worldwide turn to PHE to shape strategy, inform key healthcare decisions, and produce effective changes in policy through innovative research.

[Read More]